Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Inventory (2016 - 2025)

Apyx Medical's Change in Inventory history spans 15 years, with the latest figure at -$511000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 62.45% year-over-year to -$511000.0; the TTM value through Dec 2025 reached $1.1 million, up 147.46%, while the annual FY2025 figure was $1.1 million, 147.46% up from the prior year.
  • Change in Inventory reached -$511000.0 in Q4 2025 per APYX's latest filing, down from $865000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.8 million in Q2 2022 to a low of -$1.4 million in Q4 2024.
  • Average Change in Inventory over 5 years is $288950.0, with a median of $272000.0 recorded in 2023.
  • Peak YoY movement for Change in Inventory: soared 436.99% in 2021, then plummeted 917.31% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $877000.0 in 2021, then plummeted by 111.86% to -$104000.0 in 2022, then tumbled by 917.31% to -$1.1 million in 2023, then fell by 28.64% to -$1.4 million in 2024, then skyrocketed by 62.45% to -$511000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Change in Inventory are -$511000.0 (Q4 2025), $865000.0 (Q3 2025), and $521000.0 (Q2 2025).